GENE ONLINE|News &
Opinion
Blog

Biomanufacturing
BIO Asia-Taiwan 2026 Clinical LogisticsSupply chain resilienceTaiwan CDMO Alliance
The Agile CDMO: Taiwan’s Masterclass in Biopharma Supply Chain Resilience
2026-07-28
BIO Asia-Taiwan 2026 CDMOBiomanufacturing
The CDMO Crossroads: End-to-End Giants vs. Niche Technical Experts
2026-07-24
Ginkgo Bioworks
Ginkgo Bioworks and Merck’s Collaboration Worth Up to $144 million
2022-10-13
Prime Biomanufacturing
Will Biden’s Biomanufacturing Initiative Kill Korean Partnership?
2022-10-12
Biomanufacturing
Government Agencies Spring into Action After Biomanufacturing Executive Order
2022-09-14
Biomanufacturing
NC – Life Sciences Manufacturing Coalition Wins $25 million in Grant Funding
2022-09-02
Biofuel
Fat Away from the Land: 3rd Generation Biodiesel
2022-06-29
CDMO
Novartis and Samsung Biologics Sign Low-Profile $81 Million Deal
2022-06-10
Gene Therapy
Astellas Ups Production of Gene Therapies With New Carolina Plant
2022-06-09
Supply Chain
EQT and Mubadala to Acquire Envirotainer in $3 Billion Deal
2022-06-08
CDMO
Bora Pharmaceuticals Expands with Eden Biologics’ CDMO Purchase
2022-05-11
Fujifilm
Fujifilm’s Cell Culture Branch Acquires Recombinant Protein Maker Shenandoah
2022-03-24
COVID-19
Plant-Based COVID-19 Vaccine Approved in Canada
2022-03-01
SPAC
Psychedelics Player Goes Public via SPAC
2022-01-25
Series A FundingCDMO
China’s Innoforce Bags $157 Million to Boost Cell, Gene and RNA CDMO Services
2021-12-10
1 2
LATEST
Wendy Short Bartie Repositions Bristol Myers Squibb Corporate Affairs to Integrate Patient Advocacy and Healthcare Access
2026-09-14
Wendy Short Bartie Restructures Bristol Myers Squibb Corporate Affairs to Link Reputation with Business Performance
2026-09-14
Wendy Short Bartie Integrates Patient Advocacy and Public Trust into Bristol Myers Squibb Business Strategy
2026-09-14
Mycenax Teams Up with Global Partners to Expedite R&D and Market Launch of Next-Generation ADCs
2026-09-14
Chinese Bispecific Antibody Tops Keytruda in First Head-to-Head OS Win; SMA Muscle-Strengthening Therapy Approved, B7-H3 ADC Shows Promise
2026-09-14
GO PRIME
FDA Approves Bayer’s Sevabertinib as First-Line Treatment for Adults Living with HER2-Mutant Lung Cancer
2026-09-14
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
READ MORE
EVENT
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
2026-10-23
ESMO Congress 2026 (Oncology Breakthroughs)
Madrid, Spain
2026-10-27
ESGCT 2026 (Gene & Cell Therapy)
Hamburg, Germany
SEE MORE
Scroll to Top